Connor, Clark & Lunn Investment Management (CC&L)’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.78M | Sell |
|
|||||
|
2025
Q1 | $2.84M | Buy |
|
|||||
|
2024
Q4 | $2.34M | Buy |
|
|||||
|
2024
Q3 | $1.59M | Buy |
|
|||||
|
2024
Q2 | $621K | Buy |
|
|||||
|
2024
Q1 | $1.08M | Buy |
|
|||||
|
2023
Q4 | $854K | Sell |
|
|||||
|
2023
Q3 | $639K | Sell |
|
|||||
|
2023
Q2 | $775K | Buy |
|
|||||
|
2023
Q1 | $770K | Buy |
|
|||||
|
2022
Q4 | $859K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $26K | Sell |
|
|||||
|
2017
Q2 | $349K | Sell |
|
|||||
|
2017
Q1 | $704K | Sell |
|
|||||
|
2016
Q4 | $550K | Sell |
|
|||||
|
2016
Q3 | $1.18M | Sell |
|
|||||
|
2016
Q2 | $958K | Hold |
|
|||||
|
2016
Q1 | $893K | Sell |
|
|||||
|
2015
Q4 | $1.4M | Buy |
|
|||||
|
2015
Q3 | $994K | Buy |
|
|||||
|
2015
Q2 | $792K | Buy |
|
|||||
|
2015
Q1 | $519K | Buy |
|
|||||
|
2014
Q4 | $43K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $93K | Buy |
|